The Warsaw Voice » Business » News - March 5, 2018
You have to be logged in to use the ReadSpeaker utility and listen to a text. It's free-of-charge. Just log in to the site or register if you are not registered user yet.
PFR invests in biotechnologies
   
Polish Development Fund PFR's special purpose vehicle PFR Life Science wants to invest ca. PLN 300 million in Poland's biotechnological companies, CEO Pawel Borys says.
The comment follows a PLN 40 million investment in biotech firm Selvita under the latter's recent SPO. PFR Life Science could invest PLN 40-50 million in two other biotechnological projects even before the end of 2018, while seeing the average volume of its support for biotech firms at PLN 30-50 milllion, according to Borys.
PFR-owned PFR Ventures fund of funds will provide financial support to smaller entities in the sector, Borys says.